Kuwait Nuclear Medicine Market Size & Outlook, 2026-2033
The nuclear medicine market in Kuwait is expected to reach a projected revenue of US$ 205.2 million by 2033. A compound annual growth rate of 7.6% is expected of Kuwait nuclear medicine market from 2026 to 2033.
Revenue, 2025 (US$M)
$107.5
Estimate, 2026 (US$M)
$122.9
Forecast, 2033 (US$M)
$205.2
CAGR, 2026 - 2033
7.6%
Global Market
Related Markets
Kuwait nuclear medicine market highlights
- The Kuwait nuclear medicine market generated a revenue of USD 107.5 million in 2025 and is expected to reach USD 205.2 million by 2033.
- The Kuwait market is expected to grow at a CAGR of 7.6% from 2026 to 2033.
- In terms of segment, diagnostics was the largest revenue generating product in 2025.
- Diagnostics is the most lucrative product segment registering the fastest growth during the forecast period.
Nuclear medicine market data book summary
| Market revenue in 2025 | USD 107.5 million |
| Market revenue in 2033 | USD 205.2 million |
| Growth rate | 7.6% (CAGR from 2026 to 2033) |
| Largest segment | Diagnostics |
| Fastest growing segment | Diagnostics |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Diagnostics, Therapeutics |
| Key market players worldwide | GE HealthCare Technologies Inc Common Stock, Jubilant Pharmova, Nordion, Bracco, Iren SpA, Abliva AB, Lantheus Holdings Inc, Eckert & Ziegler Bebig SA, Mallinckrodt PLC Ordinary Shares - New, Cardinal Health Inc |
Other key industry trends
- In terms of revenue, Kuwait accounted for 0.5% of the global nuclear medicine market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Middle East & Africa, UAE nuclear medicine market is projected to lead the regional market in terms of revenue in 2033.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 292.7 million by 2033.
No credit card required*
Publish Date: Jun 17, 2026
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Nuclear Medicine Market Scope
Nuclear Medicine Market segmentation & scope
Other
Nuclear Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| GE HealthCare Technologies Inc Common Stock | View profile | 51,000 | 500 West Monroe Street, Chicago, IL, United States, 60661 | www.gehealthcare.com |
| Cardinal Health Inc | View profile | 48,000 | 7000 Cardinal Place, Dublin, OH, United States, 43017 | www.cardinalhealth.com |
| Mallinckrodt PLC Ordinary Shares - New | View profile | 2,700 | College Business and Technology Park, Cruiserath, Blanchardstown, Dublin, Ireland, 15 | www.mallinckrodt.com |
| Eckert & Ziegler Bebig SA | View profile | 501-1000 | Seneffe, Hainaut, Belgium, Europe | www.ezag.com/home/ |
| Nordion | View profile | 251-500 | Kanata, Ontario, Canada, North America | nordion.com |
| Bracco | View profile | 1001-5000 | Milan, Lombardia, Italy, Europe | www.bracco.com |
| Lantheus Holdings Inc | View profile | 834 | 201 Burlington Road, South Building, Bedford, MA, United States, 01730 | www.lantheus.com |
| Jubilant Pharmova | View profile | 10001+ | Noida, Uttar Pradesh, India, Asia | www.jubilantpharmova.com |
| Iren SpA | View profile | 10,000 | Via Nubi di Magellano, 30, Reggio Emilia, Italy, 42123 | www.gruppoiren.it |
| Abliva AB | View profile | 6 | Scheeletorget 1, Medicon Village, Lund, Sweden, 223 81 | www.abliva.com |
Kuwait Nuclear Medicine Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Nuclear Medicine Market Outlook will help companies and investors design strategic landscapes.
Diagnostics was the largest segment with a revenue share of 88.0% in 2025.
Horizon Databook has segmented the Kuwait nuclear medicine market based on diagnostics, therapeutics covering the revenue growth of each sub-segment from 2021 to 2033.
- Kuwait Nuclear Medicine Market Product Outlook (Revenue, USD Million , 2021-2033)
- Diagnostics
- Therapeutics
- Kuwait Nuclear Medicine Market Application Outlook (Revenue, USD Million , 2021-2033)
- Cardiology
- Neurology
- Oncology
- Thyroid
- Lymphoma
- Bone Metastasis
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Kuwait Nuclear Medicine Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Hospitals
- Diagnostic Centers
- Others
Reasons to subscribe to Nuclear Medicine Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Nuclear Medicine Market Outlook databook
- Our clientele includes a mix of Nuclear Medicine Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Kuwait Nuclear Medicine Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Kuwait Nuclear Medicine Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Kuwait Nuclear Medicine Market, 2021-2033 (US$M)
Kuwait nuclear medicine market statistics, by product, 2021-2033 (US$M)
